News World Center

PET Radiopharmaceuticals Market Showcase Approximately Moderate CAGR In Global Market Forecast Till 2025

Press release   •   Apr 08, 2019 06:50 EDT

According to Ameco Research, the Global PET Radiopharmaceuticals Market is projected to showcase approximately moderate CAGR during the forecast period 2018-2025.

The “Global PET Radiopharmaceuticals Market is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global PET Radiopharmaceuticals Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global PET Radiopharmaceuticals Market discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/11616

This report focuses on PET Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall PET Radiopharmaceuticals market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market-report/global-pet-radiopharmaceuticals-market-11616

Segment by Regions
North America
Europe
China
Japan

Segment by Type
F-18
Ru-82
Others

Segment by Application
Oncology
Cardiology
Neurology
Others

Available customization:

With the given market information, Ameco research offers customization's in line with the company's specific wishes. The following customization choices unit of measurement accessible for the report:
Regional and country-level analysis of the Global PET Radiopharmaceuticals Market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global PET Radiopharmaceuticals Market - Industry Size, Share, Trends and Forecast 2018 - 2025

1 PET Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of PET Radiopharmaceuticals
1.2 PET Radiopharmaceuticals Segment by Type
1.2.1 Global PET Radiopharmaceuticals Production Growth Rate Comparison by Type (2014-2025)
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 PET Radiopharmaceuticals Segment by Application
1.3.1 PET Radiopharmaceuticals Consumption Comparison by Application (2014-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.3 Global PET Radiopharmaceuticals Market by Region
1.3.1 Global PET Radiopharmaceuticals Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global PET Radiopharmaceuticals Market Size
1.4.1 Global PET Radiopharmaceuticals Revenue (2014-2025)
1.4.2 Global PET Radiopharmaceuticals Production (2014-2025)

2 Global PET Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global PET Radiopharmaceuticals Production Market Share by Manufacturers (2014-2019)
2.2 Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
2.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2014-2019)
2.4 Manufacturers PET Radiopharmaceuticals Production Sites, Area Served, Product Types
2.5 PET Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 PET Radiopharmaceuticals Market Concentration Rate
2.5.2 PET Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global PET Radiopharmaceuticals Production Market Share by Regions
3.1 Global PET Radiopharmaceuticals Production Market Share by Regions
3.2 Global PET Radiopharmaceuticals Revenue Market Share by Regions (2014-2019)
3.3 Global PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America PET Radiopharmaceuticals Production
3.4.1 North America PET Radiopharmaceuticals Production Growth Rate (2014-2019)
3.4.2 North America PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe PET Radiopharmaceuticals Production
3.5.1 Europe PET Radiopharmaceuticals Production Growth Rate (2014-2019)
3.5.2 Europe PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China PET Radiopharmaceuticals Production (2014-2019)
3.6.1 China PET Radiopharmaceuticals Production Growth Rate (2014-2019)
3.6.2 China PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan PET Radiopharmaceuticals Production (2014-2019)
3.7.1 Japan PET Radiopharmaceuticals Production Growth Rate (2014-2019)
3.7.2 Japan PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

4 Global PET Radiopharmaceuticals Consumption by Regions
4.1 Global PET Radiopharmaceuticals Consumption by Regions
4.2 North America PET Radiopharmaceuticals Consumption (2014-2019)
4.3 Europe PET Radiopharmaceuticals Consumption (2014-2019)
4.4 China PET Radiopharmaceuticals Consumption (2014-2019)
4.5 Japan PET Radiopharmaceuticals Consumption (2014-2019)

5 Global PET Radiopharmaceuticals Production, Revenue, Price Trend by Type
5.1 Global PET Radiopharmaceuticals Production Market Share by Type (2014-2019)
5.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2014-2019)
5.3 Global PET Radiopharmaceuticals Price by Type (2014-2019)
5.4 Global PET Radiopharmaceuticals Production Growth by Type (2014-2019)

6 Global PET Radiopharmaceuticals Market Analysis by Applications
6.1 Global PET Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
6.2 Global PET Radiopharmaceuticals Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in PET Radiopharmaceuticals Business
7.1 Cardinal Health Inc. (U.S.)
7.1.1 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
7.1.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Mallinckrodt plc (Ireland)
7.2.1 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Sites and Area Served
7.2.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 GE Healthcare (U.K.)
7.3.1 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Sites and Area Served
7.3.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Lantheus Medical Imaging, Inc. (U.S.)
7.4.1 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
7.4.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Bayer AG (Germany)
7.5.1 Bayer AG (Germany) PET Radiopharmaceuticals Production Sites and Area Served
7.5.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Bracco Imaging S.p.A (Italy)
7.6.1 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Sites and Area Served
7.6.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Sites and Area Served
7.7.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Nordion, Inc. (Canada)
7.8.1 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Sites and Area Served
7.8.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Advanced Accelerator Applications S.A. (France)
7.9.1 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Sites and Area Served
7.9.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 IBA Molecular Imaging (Belgium)
7.10.1 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Sites and Area Served
7.10.2 PET Radiopharmaceuticals Product Introduction, Application and Specification
7.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 PET Radiopharmaceuticals Manufacturing Cost Analysis
8.1 PET Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
8.4 PET Radiopharmaceuticals Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 PET Radiopharmaceuticals Distributors List
9.3 PET Radiopharmaceuticals Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global PET Radiopharmaceuticals Market Forecast
11.1 Global PET Radiopharmaceuticals Production, Revenue Forecast
11.1.1 Global PET Radiopharmaceuticals Production Growth Rate Forecast (2019-2025)
11.1.2 Global PET Radiopharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global PET Radiopharmaceuticals Price and Trend Forecast (2019-2025)
11.2 Global PET Radiopharmaceuticals Production Forecast by Regions (2019-2025)
11.2.1 North America PET Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.2 Europe PET Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.3 China PET Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.4 Japan PET Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
11.3 Global PET Radiopharmaceuticals Consumption Forecast by Regions (2019-2025)
11.3.1 North America PET Radiopharmaceuticals Consumption Forecast (2019-2025)
11.3.2 Europe PET Radiopharmaceuticals Consumption Forecast (2019-2025)
11.3.3 China PET Radiopharmaceuticals Consumption Forecast (2019-2025)
11.3.4 Japan PET Radiopharmaceuticals Consumption Forecast (2019-2025)
11.4 Global PET Radiopharmaceuticals Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global PET Radiopharmaceuticals Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11616

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:
Email: sales@amecoresearch.com | + 1 407 915 4157

Browse More For Latest Update :

Ameco Research